Clinical Data on Exactech Technologies for Shoulder, Knee & Ankle Replacement Surgery Presented at the 2015 Orthopaedic Resea...
March 26 2015 - 9:45AM
Business Wire
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone
and joint restoration products for hip, knee, extremities, spine
and biologic materials, presented scientific posters and
presentations regarding its latest advancements for shoulder, knee
and ankle replacement surgery during the 2015 Orthopaedic Research
Society (ORS) annual meeting in Las Vegas.
Two posters discussed computer-assisted orthopaedic surgery with
ExactechGPS® Guided Personalized Surgery, a surgeon-controlled,
real-time, patient-specific technology for reproducibility and
efficiency in total knee arthroplasty:
- Angibaud, L. et al. Effects of
Repetitive Training Practices Using an Image-Free Computer-Assisted
Guidance System on Cognitive and Technical Skills Trans. of the
61st Annual ORS Meeting, Poster #1819, 2015.
- Angibaud, L. et al. Evaluation
of Bone Deformity on Alignment Discrepancies During Total Knee
Arthroplasty Using an Image-Free Computer-Assisted Guidance System.
Trans. of the 61st Annual ORS Meeting, Poster #1820, 2015.
Four posters presented the biomechanical advantages of
Exactech’s Equinoxe® shoulder system, the fastest growing shoulder
replacement system in the United States1:
- Roche, C. et al. Optimizing
Deltoid Efficiency with Reverse Shoulder Arthroplasty Using a Novel
Glenosphere Geometry. Trans. of the 61st Annual ORS Meeting, Poster
#1011, 2015.
- Roche, C et al. A Comparison and
Correlation of Clinical Outcome Metrics in Anatomic and Reverse
Total Shoulder Arthroplasty. Trans. of the 61st Annual ORS Meeting,
Poster #2023, 2015.
- Jacobson, A. et al. Glenohumeral
Anatomy Study: A Comparison of Male and Female Shoulders with
Similar Average Age and BMI. Trans. of the 61st Annual ORS Meeting,
Poster #1842, 2015.
- Roche, C. et al. Impact of
Humeral Offset on Muscle Length with Reverse Shoulder Arthroplasty.
Trans. of the 61st Annual ORS Meeting, Poster # 1863, 2015.
An Exactech poster that highlighted foot and ankle
reconstruction was chosen by the ORS as one of the “Best of the
ORS” in its category:
- Hamilton, M. et al. Predicting
Tibial Stress Fields Around Total Ankle Replacements. Trans. of the
61st Annual ORS Meeting, Poster # 1902, 2015.
Two posters studied a process related to cartilage repair:
- Lee, P. et al. Measurement Of
Residual Enzyme And Enzyme Penetration Depth In Partially Digested
Cartilage Tissue. Trans. of the 61st Annual ORS Meeting, Poster
#1265, 2015.
- McNally, A. et al. Enzymatically
Treated Adult Cartilage Fragments for Cartilage Regeneration: Is
Fibrin Glue Appropriate for Cartilage Repair? Trans. of the 61st
Annual ORS Meeting, Poster #377, 2015.
About Exactech
Based in Gainesville, Fla., Exactech develops and markets
orthopaedic implant devices, related surgical instruments and
biologic materials and services to hospitals and physicians. The
company manufactures many of its orthopaedic devices at its
Gainesville facility. Exactech’s orthopaedic products are used in
the restoration of bones and joints that have deteriorated as a
result of injury or diseases such as arthritis. Exactech markets
its products in the United States, as well as more than 30 markets
in Europe, Latin America, Asia and the Pacific. Additional
information about Exactech, Inc. can be found at
http://www.exac.com. Copies of Exactech’s press releases, SEC
filings, current price quotes and other valuable information for
investors may be found at http://www.exac.com and
http://www.hawkassociates.com.
An investment profile on Exactech may be found at
http://www.hawkassociates.com/profile/exac.cfm. To receive future
releases in e-mail alerts, sign up at
http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, which represent
the company’s expectations or beliefs concerning future events of
the company’s financial performance. These forward-looking
statements are further qualified by important factors that could
cause actual results to differ materially from those in the
forward-looking statements. These factors include the effect of
competitive pricing, the company’s dependence on the ability of
third party manufacturers to produce components on a basis which is
cost-effective to the company, market acceptance of the company’s
products and the effects of government regulation. Results actually
achieved may differ materially from expected results included in
these statements.
References
1. Global Data. Total Shoulder Replacement – Global Analysis and
Market Forecasts. June 2013.
Exactech Inc.Investor contactsJody Phillips,
352-377-1140Executive Vice President of Finance &Chief
Financial OfficerorHawk AssociatesJulie Marshall or Frank Hawkins,
305-451-1888E-mail: EXAC@hawkassociates.comorExactech Inc.Media
contactPriscilla Bennett, 352-377-1140Vice President, Corporate
& Marketing Communication
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Apr 2023 to Apr 2024